Sartori Francesco, Puig-Diví Albert, Picañol Javier
School of Health Sciences Blanquerna, Ramon Llull University, 08022 Barcelona, Spain.
Laboratory of Neurophysiology, Biomedicine Department, Faculty of Medicine and Health Sciences, Institute of Neurosciences, University of Barcelona, 08036 Barcelona, Spain.
Neurol Int. 2025 Feb 24;17(3):34. doi: 10.3390/neurolint17030034.
Post-stroke spasticity (PSS) significantly impacts the quality of life for stroke survivors. While various treatments exist, options for refractory cases are limited. Ultrasound-guided percutaneous peripheral nerve stimulation (pPNS), commonly used in pain management, has not been studied for its potential use in spasticity management. This case report aims to evaluate the sensorimotor effects of pPNS in a patient with severe PSS.
A 38-year-old male with severe PSS and functional limitations post-ischemic stroke in the middle cerebral artery underwent a six-week pPNS protocol (12 sessions). Low-frequency (2 Hz) stimulation targeted the median, musculocutaneous, and anterior interosseous nerves, while medium-frequency (10 Hz) stimulation targeted the posterior interosseous and radial nerves. Spasticity was assessed using the Modified Ashworth Scale (MAS) and Tardieu Scale (TS). Somatosensory assessments included tactile thresholds, pressure pain thresholds, and conditioned pain modulation (CPM).
Spasticity decreased significantly, with reductions of 60.4% and 67.0% in elbow and wrist MAS scores, respectively, and a 49.5% reduction in TS scores. However, spasticity levels returned to baseline between sessions. Somatosensory assessments revealed increased tactile thresholds, decreased pressure pain thresholds, and an 81.3% reduction in CPM. The intervention was well tolerated, with minor transient effects, and the patient preferred pPNS over botulinum toxin injections.
pPNS may effectively reduce spasticity and modulate somatosensory thresholds in PSS. These preliminary findings highlight its potential as an alternative treatment for refractory PSS, warranting further research with larger sample sizes and control groups to assess its broader clinical applicability.
中风后痉挛(PSS)对中风幸存者的生活质量有重大影响。虽然存在各种治疗方法,但难治性病例的选择有限。超声引导下经皮外周神经刺激(pPNS)常用于疼痛管理,但其在痉挛管理中的潜在用途尚未得到研究。本病例报告旨在评估pPNS对一名重度PSS患者的感觉运动效应。
一名38岁男性,患有重度PSS,在大脑中动脉缺血性中风后存在功能限制,接受了为期六周的pPNS方案(12次治疗)。低频(2Hz)刺激针对正中神经、肌皮神经和骨间前神经,而中频(10Hz)刺激针对骨间后神经和桡神经。使用改良Ashworth量表(MAS)和Tardieu量表(TS)评估痉挛情况。体感评估包括触觉阈值、压痛阈值和条件性疼痛调制(CPM)。
痉挛明显减轻,肘部和腕部MAS评分分别降低60.4%和67.0%,TS评分降低49.5%。然而,各治疗疗程之间痉挛水平恢复到基线。体感评估显示触觉阈值增加,压痛阈值降低,CPM降低81.3%。该干预耐受性良好,有轻微短暂效应,患者更喜欢pPNS而非肉毒杆菌毒素注射。
pPNS可能有效降低PSS中的痉挛并调节体感阈值。这些初步发现凸显了其作为难治性PSS替代治疗方法的潜力,需要进一步开展更大样本量和对照组的研究,以评估其更广泛的临床适用性。